Grit Bio, Inc.
Research
Research
Founded in 2017
New York, New York
Overview
Email Format
Technology
News & Signals
Grit Bio, Inc. information
GritBIO is the solution to the next generation of cancer therapeutics. Through the development of peptide technologies, which target the metabolism of cancer, GritBIO is able to offer a safer approach to treating squamous cell carcinoma of the pharynx. GritBIO is also currently researching novel biological inhibitors for SARS-CoV-2. The research currently being conducted positions our company at t...
GritBIO is the solution to the next generation of cancer therapeutics. Through the development of peptide technologies, which target the metabolism of cancer, GritBIO is able to offer a safer approach to treating squamous cell carcinoma of the pharynx. GritBIO is also currently researching novel biological inhibitors for SARS-CoV-2. The research currently being conducted positions our company at the cutting edge of solutions for today's most salient problems.
Highlights
Financials
Industries
Research
Grit Bio, Inc. Frequently Asked Questions
What is Grit Bio, Inc.'s annual revenue?
Grit Bio, Inc.'s annual revenue is $null.
Where is Grit Bio, Inc.'s headquarters?
Grit Bio, Inc.'s headquarters is located in New York, New York.
How many employees does Grit Bio, Inc. have?
There are 1 employees at Grit Bio, Inc..
How many funding rounds does Grit Bio, Inc. have?
Grit Bio, Inc. has been through 0 rounds of funding.
Employees
Looking for a particular Grit Bio, Inc. Employee?
Prospect on LinkedIn
Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
